RecallRadar

FDA Drug recall D-1424-2022

FW ASPIRIN CHEWABLE TABLET 36CT SKU 913990 GS ENTERIC ASPIRIN TABLET 120 CT SKU 913724 BAYER BACK BODY EX STRGTH CAPLETS 24CT SKU 900438 BA…

On 2022-08-31 the FDA classified a Class II recall of FW ASPIRIN CHEWABLE TABLET 36CT SKU 913990 GS ENTERIC ASPIRIN TABLET 120 CT SKU 913724 BAYER BACK BODY EX STRGTH CAPLETS 24CT SKU 900438 BA… by Family Dollar Stores, citing CGMP Deviations: product held outside appropriate storage temperature conditions.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1424-2022
ClassificationClass II
Statusongoing
Initiated2022-06-23
Published2022-08-31
Last updated2026-09-13 11:52 UTC
CompanyFamily Dollar Stores
DistributionUS

Product

FW ASPIRIN CHEWABLE TABLET 36CT SKU 913990 GS ENTERIC ASPIRIN TABLET 120 CT SKU 913724 BAYER BACK BODY EX STRGTH CAPLETS 24CT SKU 900438 BAYER LOW DOSE 81 MG TABLET 120 CT SKU 916070 BAYER ASPIRIN 325MG TABLET 24CT SKU 913996 BAYER LOW DOSE TABLET 32CT SKU 915641 BAYER 81MG CHEWABLE TABLET 36 CT SKU 916078 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.

Reason

CGMP Deviations: product held outside appropriate storage temperature conditions.

Identifiers

code_infoSKUs: 913990; 913724; 900438; 916070; 913996; 915641; 916078

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1424-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.